Find patient medical information for Dextromethorphan on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Perrigo Company and Tris Pharma announced the launch of Dextromethorphan Polistirex Oral Suspension, a store brand equivalent to Reckitt Benckiser’s Delsym extended–release oral liquid suspension.

Nationwide availability for the first and only codeine-based, extended-release, oral-suspension cough/cold treatment in U.S. ENGLEWOOD, CO / ACCESSWIRE / December 6, 2018 / Aytu BioScience, Inc ...

Vernalis plc and Tris Pharma today announce that Tuzistra™ XR , extended-release oral suspension, CIII is now available to patients and physicians in the United States. Tuzistra™ XR, was ...

ALLEGAN, Mich. Perrigo on Wednesday announced that it has acquired the exclusive U.S. store brand rights to sell and distribute dextromethorphan polistirex extended-release suspension cough ...

Neos Therapeutics Acquires all Commercialization and Profit Rights to Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) from Chiesi USA and Coating Place, Inc.

Vernalis plc: Ian Garland, Chief Executive Officer +44 (0) 118 938 0015: David Mackney, Chief Financial Officer Tris Pharma, Inc: Peter Ciano, SVP, Strategy and Corporate Development ...

Neos Therapeutics, Inc. Announces Settlement of Pending Patent Litigation Concerning its Amphetamine Polistirex XR-ODT (NT-0202) with Shire LLC September 09, 2014 07:05 AM Eastern Daylight Time ...